T/CST 35-2025 Active Group standards

T/CST 35-2025 Guidelines for Compliance Evaluation of Anti-Bribery in the Pharmaceutical Industry

Publish Date: 2025-11-12 Implement Date: 2025-12-12 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CST 35-2025

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: The representation method of data elements

ICS Name: The comprehensive organization and management of the company (enterprise)

Publish Date: 2025-11-12

Implement Date: 2025-12-12

Scope

This document provides general principles, evaluation objectives, evaluation methods, evaluation content, evaluation procedures, and guidance and suggestions for quantitative scoring of evaluation indicators for anti-commercial bribery compliance evaluation in the pharmaceutical field (referring to pharmaceutical enterprises and medical and health institutions). This document is applicable to pharmaceutical enterprises and medical and health institutions conducting their own evaluations of the effectiveness of anti-commercial bribery compliance management systems, and it is also applicable to relevant entities such as state agencies, industry associations, and certification bodies conducting evaluations of the effectiveness of anti-commercial bribery compliance management systems in pharmaceutical enterprises and medical and health institutions.